HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 560.97M
Enterprise Value 359.84M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,100.85
Price/Book (mrq)0.99
Enterprise Value/Revenue 31,080.55
Enterprise Value/EBITDA 6-1.83

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-86.70%
S&P500 52-Week Change 324.65%
52 Week High 373.36
52 Week Low 34.40
50-Day Moving Average 37.87
200-Day Moving Average 313.95

Share Statistics

Avg Vol (3 month) 343.53k
Avg Vol (10 day) 348.26k
Shares Outstanding 57.82M
Float 6.87M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Dec. 12, 2019) 427.5M
Short Ratio (Dec. 12, 2019) 49.41
Short % of Float (Dec. 12, 2019) 4N/A
Short % of Shares Outstanding (Dec. 12, 2019) 42.68%
Shares Short (prior month Nov. 14, 2019) 4422.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:201
Last Split Date 3Oct. 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-62,272.20%

Management Effectiveness

Return on Assets (ttm)-31.53%
Return on Equity (ttm)-84.71%

Income Statement

Revenue (ttm)55.38k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-7.40%
Gross Profit (ttm)-313.13k
EBITDA -32.66M
Net Income Avi to Common (ttm)-54.09M
Diluted EPS (ttm)-6.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.25M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)2.16M
Total Debt/Equity (mrq)3.52
Current Ratio (mrq)1.81
Book Value Per Share (mrq)7.86

Cash Flow Statement

Operating Cash Flow (ttm)-18.42M
Levered Free Cash Flow (ttm)1.67M